Status:
COMPLETED
Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
50+ years
Brief Summary
Osteoporosis is a skeletal pathology characterized by decreased bone mass and deterioration of bone tissue. This pathology affects predominantly women, which is estimated that 40% of them will suffer ...
Eligibility Criteria
Inclusion
- Be treated with an anti-osteoporotic drug for at least three months
- Mastering the French language orally and in writing
- Have obtained the patient's oral agreement to participate in the research
- Present post-menopausal osteoporosis
- Present a densitometric osteoporosis with a T-score (-2.5) treated medically per OS (example: biphosphonates) or by subcutaneous injection (example: prolia)
- Present a history of severe osteoporotic fractures after falls of its height.
Exclusion
- Present a psychiatric history
- Present an intellectual disability
- Present major cognitive disorders related to neurodegenerative disease or other nervous system disorders.
Key Trial Info
Start Date :
June 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT04029870
Start Date
June 17 2019
End Date
January 31 2022
Last Update
March 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz Thionville
Metz, Moselle, France, 57085